medication-migraine-prevention-eptinezumab-intravenous-quarterly-chronic

Outcomes

01
pain-headache-migraine-disability-midas-score-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
02
pain-headache-migraine-monthly-disability-days-count-self-reported
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
03
pain-headache-migraine-monthly-frequency-severity-composite-midas-derived-score-self-reported
2 evidence rows
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
04
pain-headache-migraine-monthly-headache-days-below-4-binary-measured
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
05
pain-headache-migraine-monthly-headache-days-count-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
06
pain-headache-migraine-monthly-headache-mean-days-decrease-from-baseline-self-reported
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
07
pain-headache-migraine-monthly-impact-days-family-social-leisure-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
08
pain-headache-migraine-monthly-impact-days-household-work-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
09
pain-headache-migraine-monthly-impact-days-work-school-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail

medication-migraine-prevention-eptinezumab-intravenous-quarterly-chronic

Outcomes

pain-headache-migraine-disability-midas-score-self-reported

pain-headache-migraine-monthly-disability-days-count-self-reported

pain-headache-migraine-monthly-frequency-severity-composite-midas-derived-score-self-reported

pain-headache-migraine-monthly-headache-days-below-4-binary-measured

pain-headache-migraine-monthly-headache-days-count-self-reported

pain-headache-migraine-monthly-headache-mean-days-decrease-from-baseline-self-reported

pain-headache-migraine-monthly-impact-days-family-social-leisure-self-reported

pain-headache-migraine-monthly-impact-days-household-work-self-reported

pain-headache-migraine-monthly-impact-days-work-school-self-reported